The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits ...

Good morning, folks, and how are you today? Busy, no doubt. Here on the Pharmalot campus, we are maintaining the usual hectic pace as we hustle one of the short people out the door for the ride to ...

In 2007, Pharmalot officially launched; a year later, as newspapers reeled from the financial crisis, Silverman took a buyout. The story could have ended there. But over the years, Silverman (and ...

As reported on Pharmalot, Ranbaxy, the embattled generic drugmaker, holds the exclusive rights to market generic valsartan for 180 days, but has so far been unable to gain FDA approval.

And so, another working week is about to come to an end, although this was a relatively quiet few days, given that summer vacation time is drawing to a close. In fact, the moment will be ...

We also hope to hold yet another listening party with Mrs. Pharmalot, where the rotation will likely include this, this, this, this and this. And what about you?

WIKIMEDIA, KEN HAWKINS Each day, Ed Silverman, a long-time blogger and reporter, would start his morning post on Pharmalot with the chipper greeting, “Pharmalot, Pharmalittle,” plus a few words on the ...

Cardiologist William Maisel, the deputy director for science at the FDA Center of Devices and Radiological Health, was arrested on prostitution charges after being caught in an undercover sting ...

Earlier this year, its DePuy Synthes medical device unit cut all travel--except that of sales reps--for the rest of this year, hoping to cut those costs by 25%, Pharmalot notes.

Pharmalot reports that among its many shortcomings, Able did not report samples that failed to pass quality control tests, instead retesting until they got the results they needed.